Great businesses plus great growth opportunities could add up to 100% or more returns for these stocks.
News & Analysis: Vertex Pharmaceuticals
Not all stocks are expensive. These drug stocks look like bargains.
New blockbusters could be on the way for five drugmakers.
Illumina, Teladoc Health, and Vertex Pharmaceuticals enjoy strong competitive advantages and great growth opportunities.
Vertex Pharmaceuticals recently doubled down on its gene editing collaboration with CRISPR Therapeutics, but it's miles behind an arguably simpler solution.
The richest gene-editing company just got a whole lot richer.
There's at least one thing about these biotechs that the Oracle of Omaha should find especially appealing.
Two rising biotech stocks. One clear long-term winner.
This biotech checks off the two most important criteria that the greatest stocks have.
The biotech's cystic fibrosis treatment potential is far from over.